Post hoc power analysis: an idea whose time has passed?

Area of Science:

• Clinical Trials
• Statistical Analysis
• Medical Research

Background:

• Authors often face challenges when submitting manuscripts reporting negative clinical trial results.
• Post hoc analyses are frequently used but can lead to misinterpretations.
• Interpreting the adequacy of sample size in clinical trials is crucial for valid conclusions.

Purpose of the Study:

• To illustrate the potential pitfalls of post hoc analysis in the context of negative clinical trials.
• To demonstrate the utility of confidence intervals for interpreting clinical trial outcomes.
• To compare the effectiveness of confidence intervals versus post hoc power calculations in assessing sample size adequacy.

Main Methods:

• A hypothetical scenario simulating author experiences with negative clinical trial submissions was developed.
• This scenario was used to explain the application of confidence intervals in interpreting clinical trial results.
• Post hoc power calculations were also considered within the same scenario for comparison.

Main Results:

• The hypothetical scenario highlighted how post hoc analyses can obscure or misrepresent findings from negative clinical trials.
• Confidence intervals were shown to provide a more robust method for interpreting the precision of estimates.
• Confidence intervals more effectively indicated the possibility of an inadequate sample size compared to post hoc power calculations.

Conclusions:

• Confidence intervals are a superior tool for interpreting results of clinical trials, particularly those with negative findings.
• Reliance on post hoc analyses can lead to erroneous conclusions about treatment effects and study validity.
• Researchers should prioritize the use and understanding of confidence intervals to accurately assess clinical trial outcomes and sample size limitations.